Literature DB >> 2716566

Community-health needs assessment: use of the Nottingham health profile in an Australian study.

F E Baum1, R D Cooke.   

Abstract

This article reports on the use of the Nottingham health profile (which was developed in the United Kingdom as a valid and reliable indicator of perceived health status) in a community-health survey in Noarlunga, an outer suburban area of Adelaide. The instrument appears valid for use with an Australian population. It was used in Noarlunga to demonstrate a correlation between health status and a range of social and economic variables. The uses of the Nottingham health profile in health-services planning are discussed.

Mesh:

Year:  1989        PMID: 2716566

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  Health of a team competing in the 1990 World Solar Car Challenge.

Authors:  R G Moorhead; C Laurence
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

Review 2.  Evaluation of quality of life for diverse patient populations.

Authors:  K R Yabroff; B P Linas; K Schulman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  An improved questionnaire for assessing quality of life after acute myocardial infarction.

Authors:  L Valenti; L Lim; R F Heller; J Knapp
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

4.  Individual-patient monitoring in clinical practice: are available health status surveys adequate?

Authors:  C A McHorney; A R Tarlov
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

5.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care.

Authors:  J E Brazier; R Harper; N M Jones; A O'Cathain; K J Thomas; T Usherwood; L Westlake
Journal:  BMJ       Date:  1992-07-18

6.  Prevalence of obesity and affecting factors in physically disabled adults living in the city centre of Malatya.

Authors:  Çiğdem Bozkir; Ali Özer; Erkan Pehlivan
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.